These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8219662)

  • 1. Influence of topical erythromycin preparations for acne vulgaris on skin surface pH.
    Korting HC; Kerscher M; Schäfer-Korting M; Berchtenbreiter U
    Clin Investig; 1993 Aug; 71(8):644-8. PubMed ID: 8219662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical erythromycin for acne vulgaris.
    Hellgren L; Vincent J
    Dermatologica; 1980; 161(6):409-14. PubMed ID: 6452297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition.
    Strauss JS; Stranieri AM
    J Am Acad Dermatol; 1984 Jul; 11(1):86-9. PubMed ID: 6234335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M; Puhvel SM; Reisner RM
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering lesional surface pH in acne: a new treatment modality for Herpifix.
    Schürer NY; Bock M
    J Dermatolog Treat; 2009; 20(1):27-31. PubMed ID: 18618363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne.
    Dreno B; Martin R; Moyal D; Henley JB; Khammari A; Seité S
    Exp Dermatol; 2017 Sep; 26(9):798-803. PubMed ID: 28094874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical antibacterial treatments for acne vulgaris : comparative review and guide to selection.
    Tan HH
    Am J Clin Dermatol; 2004; 5(2):79-84. PubMed ID: 15109272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of a topical preparation containing erythromycin in the treatment of acne.
    Puschmann M; Meyer-Rohn J
    Dermatologica; 1982 May; 164(5):343-9. PubMed ID: 6212272
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M; Lamerz A; Franke-Hoffman M
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Delivery of Erythromycin Through Cubosomes for Acne.
    Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
    Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical antibacterial therapy for acne vulgaris.
    Dreno B
    Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acne vulgaris with topically applied erythromycin and tretinoin.
    Mills OH; Kligman AM
    Acta Derm Venereol; 1978; 58(6):555-7. PubMed ID: 83088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.